SCHEMBL300915

SCHEMBL300915

NC(=O)c1nc(-c2cccc(O)c2)nc2c1[nH]c(=O)n2-c1cccc(Cl)c1F

nearest known ligand 0.72

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 12/20 0.72
PIK3CB P42338 11/20 0.72
PIK3CG P48736 11/20 0.72
PIK3CA P42336 10/20 0.72
MAPT P10636 2/20 0.62
CSNK2A1 P68400 5/20 0.58
TP53 P04637 2/20 0.56
NPSR1 Q6W5P4 2/20 0.56
USP2 O75604 1/20 0.56
LMNA P02545 1/20 0.56
ESR1 P03372 1/20 0.56
TSHR P16473 1/20 0.56
MAPK1 P28482 1/20 0.56
HTT P42858 1/20 0.56
KDM4E B2RXH2 1/20 0.54
GAA P10253 1/20 0.54
HPGD P15428 1/20 0.54
HSD17B10 Q99714 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL300978 0.92 PIK3CD (0.68) PIK3CDPIK3CBPIK3CGPIK3CAMAPT
SCHEMBL301220 0.91 PIK3CD (0.70) PIK3CDPIK3CBPIK3CGPIK3CAMAPT
SCHEMBL301171 0.89 PIK3CD (0.75) PIK3CDPIK3CBPIK3CGPIK3CAMAPT
SCHEMBL300955 0.89 PIK3CD (0.72) PIK3CDPIK3CBPIK3CGPIK3CAMAPT
SCHEMBL300847 0.88 PIK3CD (0.71) PIK3CDPIK3CBPIK3CGPIK3CAMAPT
SCHEMBL300833 0.88 PIK3CD (0.68) PIK3CDPIK3CBPIK3CGPIK3CAMAPT
SCHEMBL300925 0.87 PIK3CD (0.70) PIK3CDPIK3CBPIK3CGPIK3CAMAPT
SCHEMBL300834 0.87 PIK3CD (0.69) PIK3CDPIK3CBPIK3CGPIK3CAMAPT
SCHEMBL301281 0.87 PIK3CD (0.66) PIK3CDPIK3CBPIK3CGPIK3CAMAPT
SCHEMBL300848 0.87 PIK3CD (0.66) PIK3CDPIK3CBPIK3CGPIK3CAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2078018-B1 HETEROARYL COMPOUNDS, COMPOSITIONS THEREOF, AND USE THEREOF AS PROTEIN KINASE INHIBITORS SIGNAL PHARM LLC (US) 2012-03-14 EP claimed
CN-107976546-B Inhibition of phosphorylation of TOR kinase inhibitory Activity markers PRAS40, GSK 3-beta, or P70S6K1 西格诺药品有限公司 2020-10-27 CN disclosed
CN-110721186-A Treatment of prostate cancer with TOR kinase inhibitors 西格诺药品有限公司 2020-01-24 CN disclosed
CN-107157990-B Treatment of cancer with TOR kinase inhibitors 西格诺药品有限公司 2020-01-07 CN disclosed
CN-102821767-A IDENTIFICATION OF LKB1 MUTATION AS A PREDICTIVE BIOMARKER FOR SENSITIVITY TO TOR KINASE INHIBITORS SIGNAL PHARM LLC 2012-12-12 CN disclosed
CN-101679432-A Heteroaryl compounds, compositions thereof, and their use as protein kinase inhibitors SIGNAL PHARM LLC 2010-03-24 CN disclosed
EP-2078018-A1 HETEROARYL COMPOUNDS, COMPOSITIONS THEREOF, AND USE THEREOF AS PROTEIN KINASE INHIBITORS Signal Pharmaceuticals LLC (US) 2009-07-15 EP disclosed
WO-2008051494-A1 HETEROARYL COMPOUNDS, COMPOSITIONS THEREOF, AND USE THEREOF AS PROTEIN KINASE INHIBITORS SIGNAL PHARMACEUTICALS, LLC (US) 2008-05-02 WO disclosed